Literature DB >> 27198526

Infants Operated on for Necrotizing Enterocolitis: Towards Evidence-Based Pain Guidelines.

Naomi J Meesters1, Monique van Dijk, Catherijne A J Knibbe, Claudia M G Keyzer-Dekker, Dick Tibboel, Sinno H P Simons.   

Abstract

BACKGROUND: Necrotizing enterocolitis (NEC) is known as an extremely painful childhood condition.
OBJECTIVES: The objective of this study was to explore pain management around NEC-related surgery in our neonatal intensive care unit (NICU) from a chart review of prospectively collected data on 60 operated NEC patients admitted between 2008 and 2013 with a median (IQR) gestational age of 28.3 (25.5-31.6) weeks.
METHODS: Pain medication data and pain scores (i.e. COMFORTneo and Numerical Rating Scale pain and distress scores) from 72 h before until 72 h after surgery were collected.
RESULTS: Preoperatively, 95% of the patients received morphine versus 100% postoperatively, with a median dosage of 10.0 (IQR 9.7-14.5) and 16.9 (IQR 10.1-20.0) μg/kg/h, respectively. Postoperatively, 28 patients (46.7%) received additional fentanyl intermittently and 14 (23.3%) received midazolam, which was part of palliative treatment for 6 patients (42.9%). In patients receiving pain medication, median COMFORTneo scores were 10 (IQR 10-11) preoperatively and 11 (10-12) postoperatively. The pain scores were comparable with those of other patients admitted to the NICU in the same time period.
CONCLUSIONS: Continuous morphine of 10 μg/kg/h preoperatively, with an increase to 15 μg/kg/h postoperatively, seems to constitute a good starting dose for further individualized pain management guided by pain scores.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27198526     DOI: 10.1159/000445284

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  1 in total

1.  Pre- and Postnatal Maturation are Important for Fentanyl Exposure in Preterm and Term Newborns: A Pooled Population Pharmacokinetic Study.

Authors:  Yunjiao Wu; Swantje Völler; Robert B Flint; Sinno H P Simons; Karel Allegaert; Vineta Fellman; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2021-11-13       Impact factor: 5.577

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.